Artal Group S.A. Morphic Holding, Inc. Call Options Transaction History
Artal Group S.A.
- $1.58 Billion
- Q2 2024
Call Options
1 transactions
Others Institutions Holding MORF
# of Institutions
118Shares Held
38.1MCall Options Held
4.2KPut Options Held
200K-
Wellington Management Group LLP Boston, MA5.81MShares$331 Million0.04% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.98MShares$284 Million6.0% of portfolio
-
Black Rock Inc. New York, NY3.53MShares$201 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.22MShares$126 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.21MShares$126 Million0.01% of portfolio
About Morphic Holding, Inc.
- Ticker MORF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,477,100
- Market Cap $2.19B
- Description
- Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...